Viewing data from:

PENICILLIN-VK

ANDA

PENICILLIN V POTASSIUM | A060456 | TEVA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.0771

per ml

Lowest NADAC/Unit

$0.0442

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093412573PENICILLIN VK 125 MG/5 ML SOLN	$0.0771	ML	Generic	—	2026-06-17
00093412773PENICILLIN VK 250 MG/5 ML SOLN	$0.0624	ML	Generic	—	2026-06-17
00093412774PENICILLIN VK 250 MG/5 ML SOLN	$0.0521	ML	Generic	—	2026-06-17
00093412574PENICILLIN VK 125 MG/5 ML SOLN	$0.0442	ML	Generic	—	2025-12-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs10 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SANDOZ GMBHPENICILLIN V POTASSIUM

DMF 132951998

BIOTIKA ASPENICILLIN V POTASSIUM

DMF 139631999

TEVA PHARMACEUTICALS USA INCInactivePENICILLIN V POTASSIUM

DMF 132131998

SQUIBBInactivePENICILLIN V POTASSIUM

DMF 132871998

LILLY RESEARCH LABORATORIESInactivePENICILLIN V POTASSIUM

DMF 133321998

BRISTOL MYERS SQUIBB COInactivePENICILLIN V POTASSIUM

DMF 133461998

GIST-BROCADES NV PHARMACEUTICALSInactivePENICILLIN V POTASSIUM

DMF 133551998

PFIZER INCInactivePENICILLIN V POTASSIUM

DMF 133751998

DISTA PRODUCTS CO DIV ELI LILLY AND COInactivePENICILLIN V POTASSIUM

DMF 134171998

PFIZER INCInactivePENICILLIN V POTASSIUM

DMF 134241998

FERMENTA PRODUCTS INCInactivePENICILLIN V POTASSIUM

DMF 135041998

GIST-BROCADES NV PHARMACEUTICALSInactivePENICILLIN V POTASSIUM

DMF 135551998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 125MG BASE/5ML

0 patents0 exclusivities▴

FOR SOLUTION;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 250MG BASE/5ML

0 patents0 exclusivities▾

FOR SOLUTION;ORAL | Approved: Approved Prior to Jan 1, 1982